Johnson & Johnson (NYSE: JNJ) Archives

daniel March 8, 2021March 8, 2021 How Much Cash and Debt does Merck have?, How Much Money is Merck Making?, Is Merck a Good Stock?, Johnson & Johnson (NYSE: JNJ), Merck (MRK), Merck & Co. (NYSE: MRK), Merck makes controversial Vaccine, Will Merck make money with Vaccines?

Will Merck & Co. (NYSE: MRK) make money with Vaccines?

Merck (MRK) will manufacture the controversial Johnson & Johnson (JNJ) single-shot vaccine, U.S. President Joe Biden (D-Delaware) announced on 3 March 2021. Biden hopes Merck and J&J could manufacture enough vaccine for every adult in the United States by May 2021.

The contract could be lucrative because there were 255.2 million adults in the United States in 2019. However, the Johnson & Johnson (NYSE: JNJ) vaccine is controversial because it is weaker.

Good Stocks

daniel January 19, 2021January 19, 2021 Can Johnson & Johnson make money with vaccines?, How Much Money does Johnson & Johnson Make?, How Much Vaccine can Johnson & Johnson produce?, Is the Johnson & Johnson Vaccine better?, Johnson & Johnson, Johnson & Johnson (JNJ), Johnson & Johnson (NYSE: JNJ), Johnson & Johnson is a tremendous dividend stock, What value does Johnson & Johnson have?, Will the Vaccine Help Johnson & Johnson

Can Johnson & Johnson make money with vaccines?

The J&J vaccine is more stable because they made it with the proven adenovirus technique. An adenovirus vaccine is a harmless cold virus that carries a coronavirus gene into human cells.

Stocks

daniel October 11, 2019October 11, 2019 How Johnson & Johnson can cash in on Medicare, How Johnson & Johnson could profit from an Aging America, Is Johnson & Johnson a Growth Stock?, Is Johnson & Johnson a Value Investment?, Is Johnson & Johnson making Money?, Johnson & Johnson (NYSE: JNJ), Johnson & Johnson is making a Lot of Money, Medicare for All, Single Payer Healthcare is Coming to America

Is Johnson & Johnson making Money?

Hence, Johnson & Johnson has a growing market for many of its products. Additionally, the government will pick up many of its customers’ tabs. Thus, I think J&J could be a cash-rich company and a growth stock for decades to come.